Bladder Cancer Treatment (PDQ®) - National Cancer Institute

full-text ► health professionals ►

Bladder Cancer Treatment (PDQ®) - National Cancer Institute

Bladder Cancer Treatment (PDQ®)

• General Information About Bladder Cancer

• Cellular Classification of Bladder Cancer

• Stage Information for Bladder Cancer

• Treatment Option Overview for Bladder Cancer

• Stage 0 Bladder Cancer Treatment

• Stage I Bladder Cancer Treatment

• Stages II and III Bladder Cancer Treatment

• Stage IV Bladder Cancer Treatment

• Recurrent Bladder Cancer Treatment

• Changes to This Summary (10/23/2014)

• About This PDQ Summary

• Get More Information From NCI
• 
  

Bladder Cancer Treatment (PDQ®)

General Information About Bladder Cancer

• Incidence and Mortality
• Anatomy
• Histopathology
• Carcinogenesis and Risk Factors
• Clinical Features
• Diagnostics
• Prognostic Factors
• Survival
• Follow-up
• Related Summaries

Incidence and Mortality

Bladder cancer is the sixth most common cancer in the United States after lung cancer, prostate cancer, breast cancer, colon cancer, and lymphoma. It is the third most common cancer in men but only the eleventh most common cancer in women. Of the roughly 70,000 new cases annually, about 53,000 are in men and about 18,000 are in women. Of the roughly 15,000 annual deaths, over 10,000 are in men and fewer than 5,000 are in women. The reasons for this disparity between the sexes are not well understood.

Estimated new cases and deaths from bladder cancer in the United States in 2014:[1]

• New cases: 74,690.
• Deaths: 15,580.

...

Anatomy of the male urinary system (left panel) and female urinary system (right panel) showing the kidneys, ureters, bladder, and urethra. Urine is made in the renal tubules and collects in the renal pelvis of each kidney. The urine flows from the kidneys through the ureters to the bladder. The urine is stored in the bladder until it leaves the body through the urethra.